CRM1 inhibition
CRM1 inhibition has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 13, 2021: “Enhanced Activity of Exportin-1/CRM1 in Neurons Contributes to Autophagy Dysfunction and Senescent Features in Old Mouse Brain”.
1 paper studies it2 findingsUpdated
See all 1 papers on CRM1 inhibition
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Comisión Nacional de Investigación Científica y Tecnológica and 5 more
- Animals1
What did studies of CRM1 inhibition find?
2Studies of CRM1 inhibition measured 2 outcomes: senescence-associated beta-galactosidase and autophagy.
Senescence-associated beta-galactosidase
downin mouse cells1
1 study
Senescence-associated beta-galactosidase
downin mouse cells1
CRM1 inhibition decreases senescence-associated beta-galactosidase in vitro model of neuronal senescence.
“CRM1 inhibition improved autophagy flux and reduced SA-β-gal activity by restoring TFEB nuclear localization”
Cellsin vitro model of neuronal senescence
Oxidative medicine and cellular longevity
Autophagy
upin mouse cells1
1 study
Autophagy
upin mouse cells1
CRM1 inhibition increases autophagy in vitro model of neuronal senescence.
“CRM1 inhibition improved autophagy flux and reduced SA-β-gal activity by restoring TFEB nuclear localization”
Cellsin vitro model of neuronal senescence
Oxidative medicine and cellular longevity